Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Replicative Cell Senescence02:15

Replicative Cell Senescence

3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
What is the Cell Cycle?00:56

What is the Cell Cycle?

6.3K
The cell cycle refers to the sequence of events occurring throughout a typical cell’s life. In eukaryotic cells, the somatic cell cycle has two stages: the interphase and the mitotic phase. During interphase, the cell grows, performs its basic metabolic functions, copies its DNA, and prepares for mitotic cell division. Then, during mitosis and cytokinesis, the cell divides its nuclear and cytoplasmic materials, respectively. This generates two daughter cells that are identical to the...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

2.9K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
2.9K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Aneuploidy selects for the acquisition of driver genes in breast cancer.

Nature·2026
Same author

Elezanumab for the treatment of spinal cord injury: assessing the clinical development journey to date.

Expert opinion on investigational drugs·2026
Same author

Munc18-1 is crucial for photoreceptor function, survival and regulation of syntaxin-3 localization and expression.

Scientific reports·2026
Same author

Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very-High-Risk and High-Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety.

International journal of cancer·2026
Same author

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
Same author

EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

Cancer discovery·2026

Video Experimental Relacionado

Updated: May 21, 2025

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
09:44

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells

Published on: September 24, 2020

4.4K

La duración del ciclo celular determina la capacidad de transformación oncogénica

Danian Chen1,2,3,4, Suying Lu1, Katherine Huang1

  • 1Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada.

Nature
|April 30, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La duración total del ciclo celular (Tc) predice la susceptibilidad al cáncer. La Tc más corta identifica linajes celulares propensos al cáncer, explicando cómo las células mutadas escapan a la transformación y resisten los mecanismos supresores normales del tumor.

Más Videos Relacionados

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

27.8K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.2K

Videos de Experimentos Relacionados

Last Updated: May 21, 2025

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
09:44

In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells

Published on: September 24, 2020

4.4K
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

27.8K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.2K

Área de la Ciencia:

  • En el campo de la oncología
  • Biología celular
  • Genética del cáncer

Sus antecedentes:

  • Las mutaciones oncogénicas son comunes en los tejidos normales, pero no siempre se desarrolla cáncer.
  • Comprender por qué algunas células mutadas se transforman mientras que otras no es crucial para la prevención del cáncer.

Objetivo del estudio:

  • Identificar las características que diferencian a los linajes celulares propensos al cáncer de los resistentes al cáncer.
  • Para determinar si la duración del ciclo celular predice la susceptibilidad al cáncer.

Principales métodos:

  • Análisis de la duración del ciclo celular (Tc) en varios modelos de cáncer.
  • Investigar las características del cáncer en las células retinianas deficientes de Rb y p107.
  • Perturbación del eje SKP2-p27-CDK2/CDK1.

Principales resultados:

  • La duración total del ciclo celular (Tc) predice consistentemente la susceptibilidad a la transformación en múltiples tipos de tumor.
  • Los linajes propensos al cáncer muestran defectos en la apoptosis, la senescencia y la vigilancia inmune.
  • El Tc más corto identificó la célula de origen en modelos de cáncer de pulmón y pituitaria Rb-, independientemente del momento de la mutación.

Conclusiones:

  • La duración relativa del ciclo celular es una característica clave del inicio del cáncer.
  • La Tc más corta distingue a los linajes propensos al cáncer de los resistentes al cáncer, lo que explica el escape de los mecanismos supresores de tumores.
  • El desarrollo del cáncer requiere más que la mera presencia de mutaciones oncogénicas.